Pharmaceuticals Russia

Russia Pet Pharmaceuticals Market Analysis, 2024–2034

Russia Pet Pharmaceuticals Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Russia · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $219.9 Mn Estimated value
Estimate 2025 $234.6 Mn 1% of the global market
Projected 2034 $420.6 Mn 79.3% Adds $186.0 Mn over 9 forecast years
CAGR 2025–2034 6.7% Faster than 33% of 160 Pharmaceuticals markets here
Key players 5
  • Russia is 1.02% of the global market.
  • In Europe, the largest is Germany at $806.1 Mn.
  • Fastest growing: Italy at 6.8% a year.
  • Russia ranks 6th of 6 by size in Europe.

Market size projection

Russia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$186.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Pet Pharmaceuticals Market market size by year, Russia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $219.9 Mn — —
2025 (base) $234.6 Mn +$14.7 Mn —
2026 (forecast) $250.4 Mn +$15.7 Mn +6.7%
2027 (forecast) $267.1 Mn +$16.8 Mn +13.8%
2028 (forecast) $285.0 Mn +$17.9 Mn +21.5%
2029 (forecast) $304.1 Mn +$19.1 Mn +29.6%
2030 (forecast) $324.5 Mn +$20.4 Mn +38.3%
2031 (forecast) $346.3 Mn +$21.7 Mn +47.6%
2032 (forecast) $369.5 Mn +$23.2 Mn +57.5%
2033 (forecast) $394.2 Mn +$24.8 Mn +68%
2034 (forecast) $420.6 Mn +$26.4 Mn +79.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $22.90 Bn
  2. US $9.85 Bn
  3. North America $10.06 Bn
  4. APAC $5.08 Bn
  5. Europe $4.76 Bn
  6. China $2.09 Bn
  7. Canada $1.83 Bn
  8. Japan $1.48 Bn
  9. Latin America $1.15 Bn
  10. Middle East $881.1 Mn
  11. Germany $806.1 Mn
  12. France $702.2 Mn
  13. UK $535.3 Mn
  14. Italy $551.1 Mn
  15. Ecuador $533.3 Mn
  16. Brazil $521.7 Mn
  17. Spain $447.8 Mn
  18. Saudi Arabia $437.5 Mn
  19. India $380.1 Mn
  20. Mexico $345.1 Mn
  21. Africa $338.1 Mn
  22. Australia $245.7 Mn
  23. Russia (this report) $234.6 Mn
  24. New Zealand $210.8 Mn
  25. South Africa $175.2 Mn
  26. UAE $102.1 Mn
  27. Egypt $62.0 Mn
  28. Philippines $46.5 Mn
  29. Malaysia $34.5 Mn
  30. Hong Kong $33.3 Mn
  31. Singapore $31.1 Mn
  32. Thailand $25.4 Mn
  33. Kenya $18.6 Mn

The Russia Pet Pharmaceuticals Market Analysis Executive Summary

Pet pharmaceuticals treat dogs, cats and other pets for parasites, pain, allergies, infections and chronic diseases.

Key segments of the pet Pharmaceuticals market include product (Parasiticides, Anti-Inflammatories and Antibiotics) and animal (Dogs, Cats and Others).

Russia Pet Pharmaceuticals Market Dynamics

Market Growth Drivers

More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the pet Pharmaceuticals market.

Opportunity

Pet insurance, diagnostics and vaccines for emerging animal diseases give the pet Pharmaceuticals market room to grow.

Market Restraints

Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the pet Pharmaceuticals market.

Competitive Landscape for Pet Pharmaceuticals Market in Russia

The pet Pharmaceuticals market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pet Pharmaceuticals Market in Russia

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for pet Pharmaceuticals. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Russia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pet Pharmaceuticals right now, from free public sources.

Latest research 6 papers since 2021 (worldwide)

  1. A cryopreserved and in vivo-in vitro validated human induced pluripotent stem cell blood-brain barrier model for reliable neurotoxicity assessment. NAM journal, 2025
  2. Automated radiofluorination of HER2 single domain antibody: the road towards the clinical translation of [(18)F]FB-HER2 sdAb. EJNMMI radiopharmacy and chemistry, 2024
  3. Brain PET Imaging in Small Animals: Tracer Formulation, Data Acquisition, Image Reconstruction, and Data Analysis. Methods in molecular biology (Clifton, N.J.), 2024
  4. Occurrence, toxicity, impact and removal of selected non-steroidal anti-inflammatory drugs (NSAIDs): A review. The Science of the total environment, 2023
  5. Finger doses due to(68)Ga-labelled pharmaceuticals in PET departments-results of a multi-centre pilot study. Journal of radiological protection : official journal of the Society for Radiological Protection, 2023
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pet Pharmaceuticals in context

Russia compared

  • Health spending per person: 1,003 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 5.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 17.8% of people (2025). World: 10.4% of people (2025). 6th highest of the 6 countries we cover in Europe.[3]

Questions, answered with public data

How much research is published on Pet Pharmaceuticals?
PubMed lists 6 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Pet Pharmaceuticals in Russia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Russia

See all
Same topic, other categories

Related on animal health

See the topic